Cees van Kooten Selected Research

Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)

1/2022

Complement Blockade in Recipients Prevents Delayed Graft Function and Delays Antibody-mediated Rejection in a Nonhuman Primate Model of Kidney Transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cees van Kooten Research Topics

Disease

20	Inflammation (Inflammations) 01/2022 - 04/2004
12	IGA Glomerulonephritis (IGA Nephropathy) 01/2020 - 10/2004
11	Reperfusion Injury 01/2022 - 04/2011
10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2021 - 09/2004
9	Kidney Diseases (Kidney Disease) 01/2022 - 01/2017
7	Infections 12/2021 - 04/2003
7	Diabetic Nephropathies (Diabetic Nephropathy) 12/2020 - 03/2003
7	Fibrosis (Cirrhosis) 10/2018 - 12/2003
6	Glomerulonephritis 02/2019 - 05/2004
6	Proteinuria 01/2019 - 06/2006
5	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021 - 01/2018
5	Lupus Nephritis 01/2020 - 04/2005
5	Autoimmune Diseases (Autoimmune Disease) 12/2019 - 04/2003
5	Ischemia 01/2019 - 04/2003
4	Necrosis 01/2020 - 07/2002
4	Vasculitis (Vasculitides) 01/2020 - 02/2019
4	Neoplasms (Cancer) 01/2020 - 04/2003
3	Delayed Graft Function 01/2022 - 12/2017
3	Thrombotic Microangiopathies 12/2021 - 02/2017
3	Renal Insufficiency (Renal Failure) 12/2021 - 08/2007
3	Albuminuria 11/2017 - 09/2004
3	Disease Progression 10/2016 - 12/2006
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2016 - 08/2007
2	COVID-19 01/2022 - 03/2021
2	Brain Death (Brain Dead) 01/2022 - 01/2018
2	Vascular System Injuries 12/2020 - 08/2020
2	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 12/2018
2	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 12/2018 - 09/2009
2	Wounds and Injuries (Trauma) 01/2017 - 01/2016
2	Body Weight (Weight, Body) 11/2015 - 12/2014
2	Opportunistic Infections (Opportunistic Infection) 11/2015 - 12/2014
2	Chronic Kidney Failure (Chronic Renal Failure) 12/2014 - 06/2013
2	Communicable Diseases (Infectious Diseases) 12/2014 - 04/2004
1	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2021
1	Rheumatoid Arthritis 07/2021
1	Coronavirus Infections 03/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Atypical Hemolytic Uremic Syndrome 01/2020
1	Hypertensive Nephropathy 01/2020
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2020
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2020

Drug/Important Bio-Agent (IBA)

22	Complement System Proteins (Complement)IBA 01/2022 - 04/2005
12	Immunoglobulin A (IgA)IBA 02/2016 - 10/2004
6	AntigensIBA 12/2021 - 04/2004
6	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 01/2018
6	LectinsIBA 09/2009 - 04/2004
5	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2020 - 05/2012
5	AutoantibodiesIBA 12/2019 - 09/2004
4	Rituximab (Mabthera)FDA Link 01/2021 - 01/2018
4	Antigen-Antibody Complex (Immune Complex)IBA 02/2019 - 01/2018
4	CytokinesIBA 01/2019 - 04/2004
4	Immunoglobulin G (IgG)IBA 12/2018 - 01/2007
4	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 03/2018 - 12/2006
3	VaccinesIBA 01/2022 - 04/2003
3	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 12/2014
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2016
3	Lipocalin-2IBA 12/2017 - 08/2014
3	Glucose (Dextrose)FDA LinkGeneric 07/2004 - 03/2003
2	COVID-19 VaccinesIBA 01/2022 - 03/2021
2	Pharmaceutical PreparationsIBA 12/2021 - 10/2013
2	Liposomes (Liposome)IBA 07/2021 - 01/2018
2	belimumabIBA 01/2021 - 01/2018
2	GlucocorticoidsIBA 01/2021 - 01/2018
2	ThrombomodulinIBA 12/2020 - 08/2020
2	MicroRNAs (MicroRNA)IBA 12/2020 - 06/2013
2	DNA (Deoxyribonucleic Acid)IBA 02/2019 - 01/2019
2	Nucleosomes (Nucleosome)IBA 02/2019 - 10/2011
2	ProperdinIBA 01/2019 - 12/2018
2	LigandsIBA 12/2018 - 10/2013
2	Anaphylatoxin C5a ReceptorIBA 10/2018 - 01/2018
2	Interleukin-10 (Interleukin 10)IBA 10/2018 - 06/2013
2	EnzymesIBA 11/2017 - 12/2010
2	Proteins (Proteins, Gene)FDA Link 10/2016 - 04/2004
2	Peptides (Polypeptides)IBA 10/2013 - 09/2011
2	CD40 Ligand (CD40L)IBA 10/2013 - 04/2010
2	AntibodiesIBA 10/2011 - 09/2004
2	antiglomerular basement membrane antibodyIBA 09/2009 - 09/2004
2	Secretory Immunoglobulin A (SIgA)IBA 01/2008 - 11/2007
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2004 - 03/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2003 - 03/2003
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2022
1	SteroidsIBA 12/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2021
1	C-Reactive ProteinIBA 12/2021
1	Immunoglobulins (Immunoglobulin)IBA 12/2021
1	Neutralizing AntibodiesIBA 03/2021
1	Interferon Type IIBA 03/2021
1	PTX3 proteinIBA 01/2021
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2021
1	Long Noncoding RNAIBA 12/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Coloring Agents (Dyes)IBA 01/2020
1	Myeloblastin (Proteinase 3)IBA 02/2019
1	Peroxidase (Myeloperoxidase)IBA 02/2019

Therapy/Procedure

11	Kidney Transplantation 01/2022 - 08/2007
11	Transplantation 01/2022 - 04/2003
6	Therapeutics 12/2021 - 04/2004
3	Organ Transplantation 01/2021 - 08/2007
1	Immunomodulation 01/2021